These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22917585)

  • 1. Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases.
    Friedrich B; Euler P; Ziegler R; Kuhn A; Landwehrmeyer BG; Luthi-Carter R; Weiller C; Hellwig S; Zucker B
    Brain Res; 2012 Oct; 1481():37-48. PubMed ID: 22917585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
    Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
    J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
    Furrer SA; Waldherr SM; Mohanachandran MS; Baughn TD; Nguyen KT; Sopher BL; Damian VA; Garden GA; La Spada AR
    Hum Mol Genet; 2013 Mar; 22(5):890-903. PubMed ID: 23197655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum.
    Ebner BA; Ingram MA; Barnes JA; Duvick LA; Frisch JL; Clark HB; Zoghbi HY; Ebner TJ; Orr HT
    J Neurosci; 2013 Mar; 33(13):5806-20. PubMed ID: 23536093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
    Ingram M; Wozniak EAL; Duvick L; Yang R; Bergmann P; Carson R; O'Callaghan B; Zoghbi HY; Henzler C; Orr HT
    Neuron; 2016 Mar; 89(6):1194-1207. PubMed ID: 26948890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice.
    Euler P; Friedrich B; Ziegler R; Kuhn A; Lindenberg KS; Weiller C; Zucker B
    Neurosci Lett; 2012 May; 517(1):7-12. PubMed ID: 22712074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
    Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
    Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
    Garden GA; Libby RT; Fu YH; Kinoshita Y; Huang J; Possin DE; Smith AC; Martinez RA; Fine GC; Grote SK; Ware CB; Einum DD; Morrison RS; Ptacek LJ; Sopher BL; La Spada AR
    J Neurosci; 2002 Jun; 22(12):4897-905. PubMed ID: 12077187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.
    Luthi-Carter R; Strand AD; Hanson SA; Kooperberg C; Schilling G; La Spada AR; Merry DE; Young AB; Ross CA; Borchelt DR; Olson JM
    Hum Mol Genet; 2002 Aug; 11(17):1927-37. PubMed ID: 12165555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.
    Niewiadomska-Cimicka A; Doussau F; Perot JB; Roux MJ; Keime C; Hache A; Piguet F; Novati A; Weber C; Yalcin B; Meziane H; Champy MF; Grandgirard E; Karam A; Messaddeq N; Eisenmann A; Brouillet E; Nguyen HHP; Flament J; Isope P; Trottier Y
    J Neurosci; 2021 Jun; 41(22):4910-4936. PubMed ID: 33888607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
    Garden GA; La Spada AR
    Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-Mediated CAG-Targeting Selectively Reduces Polyglutamine-Expanded Protein and Attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model.
    Niewiadomska-Cimicka A; Fievet L; Surdyka M; Jesion E; Keime C; Singer E; Eisenmann A; Kalinowska-Poska Z; Nguyen HHP; Fiszer A; Figiel M; Trottier Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
    Kang S; Hong S
    Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases.
    Branco J; Al-Ramahi I; Ukani L; Pérez AM; Fernandez-Funez P; Rincón-Limas D; Botas J
    Hum Mol Genet; 2008 Feb; 17(3):376-90. PubMed ID: 17984172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
    Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
    Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine (PolyQ) diseases: genetics to treatments.
    Fan HC; Ho LI; Chi CS; Chen SJ; Peng GS; Chan TM; Lin SZ; Harn HJ
    Cell Transplant; 2014; 23(4-5):441-58. PubMed ID: 24816443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.
    Kotliarova S; Jana NR; Sakamoto N; Kurosawa M; Miyazaki H; Nekooki M; Doi H; Machida Y; Wong HK; Suzuki T; Uchikawa C; Kotliarov Y; Uchida K; Nagao Y; Nagaoka U; Tamaoka A; Oyanagi K; Oyama F; Nukina N
    J Neurochem; 2005 May; 93(3):641-53. PubMed ID: 15836623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin 1 receptor activation restores normal mTORC1 signaling and is protective to Purkinje cells of SCA mice.
    Wozniak EAL; Chen Z; Paul S; Yang P; Figueroa KP; Friedrich J; Tschumperlin T; Berken M; Ingram M; Henzler C; Pulst SM; Orr HT
    Cell Rep; 2021 Oct; 37(2):109831. PubMed ID: 34644575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.